Anaplastic thyroid carcinoma (ATC) is a rare malignancy, accounting for 1–2% of all thyroid
cancers. Although rare, ATC accounts for the majority of deaths from thyroid carcinoma. ATC …

Simple Summary Anaplastic thyroid carcinoma (ATC) has a dismal prognostic.
Chemotherapy and radiotherapy are the mainstem options for patients with ATC. In selected …

Background: Anaplastic thyroid cancer (ATC) is a rare but highly lethal form of thyroid
cancer. Since the guidelines for the management of ATC by the American Thyroid …

Background: Anaplastic thyroid cancer (ATC) is a rare but highly lethal form of thyroid
cancer. Rapid evaluation and establishment of treatment goals are imperative for optimum …

Background: Thyroid carcinoma is the most common malignant endocrine tumor; the
anaplastic thyroid cancer subtype is aggressive and has a poor prognosis. However, there is …

Background: The aim of this study was to describe the oncologic outcomes of patients with
BRAFV600E-mutated anaplastic thyroid cancer (ATC) who had neoadjuvant BRAF-directed …

BACKGROUND Anaplastic thyroid carcinoma (ATC) is rare but is one of the most aggressive
human malignancies. Several prognostic factors have been observed in patients with ATC …

Anaplastic thyroid cancer (ATC) is an uncommon malignancy of the thyroid. Only 1‐2% of
thyroid cancers are anaplastic, but the disease contributes to 14–50% of the mortality with a …

Introduction Over the past years, the incidence of thyroid cancer has surged not only in
Germany but also in other countries of the Western hemisphere. This surge was first and …

Anaplastic thyroid cancer (ATC) is a rare malignancy. While external beam radiation therapy
has improved locoregional control, the median survival of∼ 4 months has not changed in …